rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2002-8-21
|
pubmed:abstractText |
Mononuclear cells (MNC) from patients with aplastic anemia (AA) can inhibit hematopoietic colony formation from normal bone marrow (BM) cells. Interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) are considered as soluble mediators of BM suppression in AA. Because of its cytokine synthesis inhibiting action, interleukin-10 (IL-10) could be a potentially useful molecule to modulate the hematopoietic effects of MNC from patients with AA.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1466-4860
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
206-13
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12189567-Adult,
pubmed-meshheading:12189567-Anemia, Aplastic,
pubmed-meshheading:12189567-Antibodies, Monoclonal,
pubmed-meshheading:12189567-Colony-Forming Units Assay,
pubmed-meshheading:12189567-Female,
pubmed-meshheading:12189567-Growth Inhibitors,
pubmed-meshheading:12189567-Humans,
pubmed-meshheading:12189567-Interferon-gamma,
pubmed-meshheading:12189567-Interleukin-10,
pubmed-meshheading:12189567-Leukocytes, Mononuclear,
pubmed-meshheading:12189567-Male,
pubmed-meshheading:12189567-Middle Aged,
pubmed-meshheading:12189567-Recombinant Proteins,
pubmed-meshheading:12189567-Tumor Necrosis Factor-alpha
|
pubmed:year |
2002
|
pubmed:articleTitle |
Interleukin-10 inhibits in vitro hematopoietic suppression and production of interferon-gamma and tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with aplastic anemia.
|
pubmed:affiliation |
Division of Hematology, University of Vienna, Vienna, Austria. klaus.geissler@akh-wien.ac.at
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|